Areva, Inc. (Areva)

Oncology Corporate Profile

HQ Location

7207 IBM Drive
Charlotte, NC 28262

Company Description

AREVA Med is an AREVA subsidiary specializing in the development of innovative therapies to fight cancer. AREVA Med has developed new processes for producing high purity lead-212 ((2)(1)(2)Pb), a rare radioactive isotope that is currently at the heart of promising nuclear medicine research. In 2011, AREVA Med acquired Macrocyclics, the global leader in high performance chelating agent technology.


This company does not have any commercial products
  • Brand
  • Generic
  • Investigational
Brand / Product Class Area of Study Phase Partnership
BAL101553microtubule inhibitorVarious cancer typesI
Pb-TCMC-trastuzumabalpha radioimmunoconjugateVarious cancer typesI

View additional information on product candidates here »


Recent News Headlines